Please add to your safe senders list.

The SITC Immune Monitor

Support SITC    Membership    Meetings    About SITC    

February 2016 – In this Issue

Society Updates | New Fellowship Opportunity | Education & Events | Membership 
Publications & Resources | Careers

A Message from the President

Dear Colleagues,

We’re only a few months into 2016 and it’s already shaping up to be a monumental year—not only for the field of cancer immunotherapy but also for SITC as we prepare to embark on a number of new initiatives and educational activities throughout the year.

As the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy, we work hard to ensure all of our members—students, clinicians, scientists, industry professionals and government representatives alike—have access to and are engaged in the implementation of timely, cutting-edge translational clinical research in cancer immunotherapy. Whether you’re a student or an established professional in the field, there are opportunities to advance personally and professionally at SITC. Learn more about SITC membership and how you can help shape the success of the Society in 2016 here.

With more activities scheduled in 2016 than ever before there’s no reason 2016 shouldn’t be yet another record-breaking year!

Best regards,

Howard L. Kaufman, MD, FACS
SITC President

Society Updates

SITC Cancer Immunotherapy Fellowship Submission Period Ending Soon!

In concert with the Society’s mission to improve cancer patient outcomes through the development and application of cancer immunotherapy, SITC is presenting to SITC student members several one-year fellowship opportunities, which were made possible through the generosity of AstraZeneca, EMD Serono, and Genentech. Applications will be accepted through Monday, March 7, 2016. Learn more and apply here.

New Opportunity!

Announcing the 2016 NCI Cancer Immunotherapy Fellowship
Co-sponsored by the National Cancer Institute and the Society for Immunotherapy of Cancer and made possible in part by an educational grant from EMD-Serono.

The Society for Immunotherapy of Cancer (SITC) is proud to announce the launch of the National Cancer Institute (NCI) Cancer Immunotherapy Fellowship. This award, co-sponsored by the NCI Center for Cancer Research and SITC and made possible in part by an educational grant from EMD-Serono, will provide a young investigator with an opportunity to further their education and experience in the field of cancer immunotherapy.

This training program is designed for physicians who have completed a medical oncology fellowship program in the United States and who seek specialized training in immunotherapy with clinical trials and clinical trial development. The 1-year program, at the CCR in Bethesda, Maryland, allows the fellow to have exposure to multiple clinical immunotherapeutic approaches, and also to key opinion leaders in the field of clinical immunotherapy. This fellowship provides opportunities to understand how to design, write, and run clinical trials, how to treat patients, how to manage toxicities, as well as opportunities to work with multiple experimental agents.

Get more information, including eligibility requirements,
here. Applications for the NCI Cancer Immunotherapy Fellowship will be accepted through March 21, 2016.

Education & Events

Immunotherapy Biomarkers 2016: Overcoming the Barriers
Cosponsored with the National Cancer Institute

Friday, April 1, 2016 • 8 a.m. – 5 p.m.
National Institutes of Health Campus • Bethesda, Maryland

"Cancer immunotherapy biomarkers are an area of critical need in the field," states SITC Vice President and SITC Immune Biomarkers Task Force Chair, Lisa H. Butterfield, PhD. "They provide insight into mechanism of action, and can help predict who should be enrolled into clinical trials, or at least who is likely to benefit. At this meeting, the SITC Immune Biomarkers Task Force Working Groups will present their summaries of the state of the field, identify hurdles, highlight new opportunities and make recommendations, all in a one day program."

Learn more and register here.

Cancer Immunotherapy 101 in Milwaukee, Wisconsin

Register Early for Best Rates!

Thursday, April 7, 2016 • 5 p.m. – 8:45 p.m.
Hilton Milwaukee City Center

Part of the Advances in Cancer ImmunotherapyTM series, this introductory, CME- and CE-certified program will provide clinical oncologists, nurses, pharmacists, and the entire team involved in treating cancer patients with a greater understanding of cancer immunotherapies, their therapeutic effectiveness, and the appropriate selection and management of patients.

Learn more and register here by March 17, 2016 at 5 p.m. ET for discounted early registration rates.

Can't make it to Milwaukee? More dates and locations are available!

Save the Dates for SITC 2016 – November 9-13, 2016

Gaylord National Hotel & Convention Center • National Harbor, Maryland

Mark your calendars for SITC's 31st Annual Meeting & Associated Programs! Known as the premier destination for scientific exchange, education and networking in the cancer immunotherapy field, this is the conference you don't want to miss. Learn more.

31st Annual Meeting Highlights

Keynote Speakers
Ira Mellman, PhD – Genentech

Suzanne L. Topalian, MD – Johns Hopkins University, 2016 Richard V. Smalley, MD Memorial Award Keynote Address

Featured Annual Meeting Topics

  • Adoptive Cellular Therapy vs. Bispecific Antibodies
  • Clinical Management (part of the Nurse/Pharmacist track)
  • Combination Immunotherapy
  • Diet, Exercise, Stress and the Impact on the Immune System
  • Emerging Technologies
  • Inflammation, Innate Immunity and Microbiome
  • Metabolism: Dendritic cells, T cells, Aging, Tumors
  • Promoting and Measuring Anti-Tumor Immunity
  • Tumor Immunology 101 (part of the Nurse/Pharmacist track)
  • Tumor Microenvironment
  • Value of Cancer Immunotherapy

Membership Makes a Difference

Do You Love Being a Part of SITC? Connect-a-Colleague!

New members often join SITC because a current member has invited them. Please encourage your colleagues, including nurses, pharmacists, and students, to become official SITC members by sending personalized invitations with our online tool. If each SITC member recruits two others, we could quickly grow to 3,000 members!

Membership benefits include:

  • Discounted registration rates on all SITC programs
  • Eligibility to apply for SITC fellowships and grants, available exclusively to SITC members
  • Free access to SITC "Members Only" section, including meeting slides and other online resources
  • Free access to SITC's online member directory
  • Waived article processing charges (a $2,500 USD savings) for SITC’s open access journal, the Journal for ImmunoTherapy of Cancer (JITC)
  • ... and much more!

Top referrers will receive recognition for their efforts. To connect a colleague, log in to your member profile here!

Not a member yet? Join today!

SITC is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy. As a member, you will join a growing network of nearly 1,300 basic and translational scientists, practitioners, healthcare professionals, government leaders, and industry professionals worldwide.

There are several membership categories including: Regular, Affiliate, Allied Health, Emeritus, Nurse and Physician Extender, Patient and Patient Advocate, Pharmacist, and Scientist-in-Training/Student memberships. To learn more about these categories, and to apply, visit the Membership page.

Already a Member? Don't Forget to Renew!

Renew your membership here or call our office at +1 414-271-2456.

Publications & Resources

Journal for ImmunoTherapy of Cancer, the Resource for Cutting-Edge Science in the Field

Journal for ImmunoTherapy of Cancer (JITC) is SITC's official open access, peer-reviewed journal. It encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research to clinical application. As the global voice of the Society, JITC is the resource for SITC publications and also serves as a targeted outlet for publication of original research articles, literature reviews and position papers. 

Additionally, JITC features monthly technology primers produced by the SITC Immune Biomarkers Task Force. A hot topic in the field, these papers examine the latest in biomarker technologies for cancer immunotherapy. Access the articles here, and join us in Bethesda, Maryland on April 1 for Immunotherapy Biomarkers 2016: Overcoming the Barriers. 

Interested in publishing in JITC? SITC members receive waived article processing charges for papers accepted through 2016. Submit your manuscript here.

Latest Career Opportunities from SITC's Job Board

Senior Scientist Immunology (PhD)
DCPrime - Netherlands

Senior Scientist Immuno-Oncology (PhD)
DCPrime - Netherlands

Senior Technician
DCPrime - Netherlands

Vice President, Clinical Development
Biopharmaceutical Company - Bay Area

View All Job Board Listings

If you are interested in posting an open position to SITC's job board, please reference this agreement form for posting criteria or contact SITC at


Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email:

© 2016 Society for Immunotherapy of Cancer

Join us on:

Twitter  LinkedIn  YouTube  Oncology Tube

If you do not wish to be included in our mailing list, please forward this message to with the word "Remove" in the subject line.

Please add to your safe senders list.